Trial Profile
A Retrospective, Multi-centre study to evaluate the efficacy and safety of Sofosbuvir and Ribavirin in Elderly patients with Genotype 2 Chronic HCV Infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 May 2018
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 30 May 2018 New trial record